Pascale This - Concepedia

Author

Pascale This

Institut Curie

Also Known As

P This, P. This, Pascale This, This, Pascale

Publications

712

Citations

H-Index

Concepts

All Affiliations

Institut Curie UniCancer Group Centre Hospitalier de Niort Délégation Paris 5 Hôpital Tenon

About

Pascale This is an author at Institut Curie specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	46
2	Health Sciences	1	1	30
3	Public Health	1	1	16
4	Obstetrics	1	1	16
5	Pharmacology	1	1	30

Pascale This

Publications

298

Citations

H-Index

Page 1

	Year	Citations
Prevalence and associated factors of sexual problems after early‐stage breast cancer treatment: results of a French exploratory survey Anne Brédart, Sylvie Dolbeault, Alexia Savignoni, Psycho-Oncology	2010	118
Prophylactic salpingo‐oophorectomy in a series of 89 women carrying a <i>BRCA1</i> or a <i>BRCA2</i> mutation F. Laki, Youlia Kirova, Pascale This Cancer	2007	52
[Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. Bruno Cutuli, Alain Fourquet, Élisabeth Luporsi, PubMed	2005	39
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial Pascal Pujol, Christine Lasset, Pascaline Berthet, Familial Cancer Liber TrialBreast OncologyBrca1/2 Mutations CarriersMedicinePharmacology	2011	30
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome Pascale This, Anne de la Rochefordière, Alexia Savignoni, Familial Cancer Brca2 Germline MutationBreast OncologyCancer RiskCancer EpidemiologyPatient Choices	2012	16
[Breast cancer and fertility: critical review, considerations and perspectives]. Pascale This PubMed	2008	13
113 Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long term results and review of the literature Y. Kirova, Alexia Savignoni, Brigitte Sigal‐Zafrani, European Journal of Cancer Supplements	2010	10
Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women H Rozenbaum, Olivier Chevallier, Monish Moyal, Climacteric	2002	10
Five year letrozole versus placebo in <i>BRCA1/2</i> germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial. Pascal Pujol, Lise Roca, Alain Lortholary, Journal of Clinical Oncology	2020	10

Page 1